written on 01.01.2012

Library > Country Reports > Hungary


This report offers companies, investors, policymakers, and stakeholders crucial insight into Hungary; a country with more than 100 years of history in pharmaceuticals and a leading regional role in the industry. Regulatory reform post-2008 has seen Hungary weather the storm of economic recession and re-establish itself as a hub for world-class R&D, with a concentration of pharma MNCs, a growing number of biotech SMEs, innovative research institutions, and a highly skilled and affordable workforce.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Hungarian healthcare and pharma sectors.

We use cookies to ensure that we give you the best experience on our site. For more info click here